{"protocolSection": {"identificationModule": {"nctId": "NCT02661217", "orgStudyIdInfo": {"id": "CLCZ696B2401"}, "secondaryIdInfos": [{"id": "2015-003266-87", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event", "officialTitle": "A Multicenter, Randomized, Open Label, Parallel Group Study Comparing Pre-discharge and posT-discharge tReatment Initiation With LCZ696 in heArt Failure patieNtS With Reduced ejectIon-fracTion hospItalized for an Acute decOmpensation eveNt (ADHF)", "acronym": "TRANSITION"}, "statusModule": {"statusVerifiedDate": "2021-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-02-12", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-02-20", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-06-20", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-01-19", "studyFirstSubmitQcDate": "2016-01-19", "studyFirstPostDateStruct": {"date": "2016-01-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-06-20", "resultsFirstSubmitQcDate": "2021-03-29", "resultsFirstPostDateStruct": {"date": "2021-04-26", "type": "ACTUAL"}, "dispFirstSubmitDate": "2019-01-28", "dispFirstSubmitQcDate": "2019-01-28", "dispFirstPostDateStruct": {"date": "2019-01-30", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-03-29", "lastUpdatePostDateStruct": {"date": "2021-04-26", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false, "isUsExport": true}, "descriptionModule": {"briefSummary": "To explore two modalities of treatment initiation (Pre-discharge, and Post-discharge) with LCZ696 in HFrEF patients following stabilization after an ADHF episode."}, "conditionsModule": {"conditions": ["Heart Failure With Reduced Ejection Fraction"], "keywords": ["Acute decompensated heart failure", "Reduced ejection fraction", "Pre-discharge treatment", "Post-discharge treatment", "Angiotensin receptor neprilysine inhibitor", "HFrEF"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "SUPPORTIVE_CARE", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 1002, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Pre-discharge treatment initiation", "type": "OTHER", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge.", "interventionNames": ["Drug: LCZ696"]}, {"label": "Post-discharge treatment initiation", "type": "OTHER", "description": "Patients received first dose after discharge and up to 14 days thereafter.", "interventionNames": ["Drug: LCZ696"]}], "interventions": [{"type": "DRUG", "name": "LCZ696", "description": "LCZ696 film-coated tables were supplied to the investigators. Tablets were taken with a glass of water, and were administered with or without food.\n\nThe target dose of LCZ696 was 200 mg twice daily. Starting dose of LCZ696 was either 50 or 100 mg, twice daily. The dose of LCZ696 should be doubled every 2-4 weeks to achieve the target dose of 200 mg twice daily, as tolerated by the patient.", "armGroupLabels": ["Post-discharge treatment initiation", "Pre-discharge treatment initiation"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Percentage of Patients Achieving the Target Dose of LCZ696 200 mg Bid at 10 Weeks Post Randomization", "description": "Percentage of patients achieving and maintaining LCZ696 200 mg bid for at least 2 weeks leading to Week 10", "timeFrame": "10 weeks after Randomization"}], "secondaryOutcomes": [{"measure": "Percentage of Patients Achieving and Maintaining Either LCZ696 100 mg and/or 200 mg Bid", "description": "Percentage of patients achieving and maintaining either LCZ696 100 mg and/or 200 mg bid for at least 2 weeks leading to Week 10", "timeFrame": "10 weeks after Randomization"}, {"measure": "Percentage of Patients Achieving and Maintaining Any Dose of LCZ696", "description": "Percentage of patients achieving any dose of LCZ696 for at least 2 weeks leading to 10 weeks of treatment", "timeFrame": "10 weeks after Randomization"}, {"measure": "Percentage of Patients Permanently Discontinued From Treatment", "description": "Percentage of patients permanently discontinued from LCZ696 (1) up to week 10 due to AEs, and (2) up to week 26 due to any reasons", "timeFrame": "10 weeks after Randomization AND 26 weeks after randomization"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients hospitalized due to acute decompensated HF episode (ADHF) as primary diagnosis) and consistent Signs \\& Symptoms\n2. Diagnosis of HF New York Heart Association class II-to-IV and reduced ejection fraction: Left ventricular ejection fraction \u2264 40% at Screening\n3. Patients did not receive any IV vasodilators (except nitrates), and/or any IV inotropic therapy from the time of presentation for ADHF to Randomization\n4. Stabilized (while in the hospital) for at least 24 hours leading to Randomization.\n5. Meeting one of the following criteria:\n\n   * Patients on any dose of ACEI or ARB at screening\n   * ACEI/ARB na\u00efve patients and patients not on ACEI or ARB for at least 4 weeks before screening.\n\nExclusion Criteria:\n\n1. History of hypersensitivity to the sacubitril, valsartan, or any ARBs, NEP inhibitors or to any of the LCZ696 excipients.\n2. Symptomatic hypotension and/or a SBP below 110 mm Hg or SBP above 180 mm Hg prior to randomization\n3. End stage renal disease at Screening; or estimated GFR below 30 mL/min/1.73 m2 (as measured by MDRD formula at Randomization.\n4. Serum potassium above 5.4 mmol/L at Randomization.\n5. Known history of hereditary or idiopathic angioedema or angioedema related to previous ACE inhibitor or ARB therapy\n6. Severe hepatic impairment, biliary cirrhosis and cholestasis", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals", "affiliation": "Novartis Pharmaceuticals", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Novartis Investigative Site", "city": "Quilmes", "state": "Buenos Aires", "zip": "B1878DKF", "country": "Argentina", "geoPoint": {"lat": -34.72904, "lon": -58.26374}}, {"facility": "Novartis Investigative Site", "city": "Villa Maria", "state": "Cordoba", "zip": "X5900JKA", "country": "Argentina", "geoPoint": {"lat": -32.40751, "lon": -63.24016}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1405CNF", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1426BOR", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Cordoba", "zip": "X5000", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Novartis Investigative Site", "city": "Salta", "zip": "4400", "country": "Argentina", "geoPoint": {"lat": -24.7859, "lon": -65.41166}}, {"facility": "Novartis Investigative Site", "city": "Tucuman", "zip": "T4000NIJ", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "Novartis Investigative Site", "city": "Bruxelles", "zip": "1200", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"facility": "Novartis Investigative Site", "city": "Genk", "zip": "3600", "country": "Belgium", "geoPoint": {"lat": 50.965, "lon": 5.50082}}, {"facility": "Novartis Investigative Site", "city": "Huy", "zip": "4500", "country": "Belgium", "geoPoint": {"lat": 50.51894, "lon": 5.23284}}, {"facility": "Novartis Investigative Site", "city": "Leuven", "zip": "3000", "country": "Belgium", "geoPoint": {"lat": 50.87959, "lon": 4.70093}}, {"facility": "Novartis Investigative Site", "city": "Ronse", "zip": "9600", "country": "Belgium", "geoPoint": {"lat": 50.74574, "lon": 3.6005}}, {"facility": "Novartis Investigative Site", "city": "Vancouver", "state": "British Columbia", "zip": "V5Z 1M9", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "Novartis Investigative Site", "city": "Hamilton", "state": "Ontario", "zip": "L8L 2X2", "country": "Canada", "geoPoint": {"lat": 43.25011, "lon": -79.84963}}, {"facility": "Novartis Investigative Site", "city": "Montreal", "state": "Quebec", "zip": "H3A 1A1", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Novartis Investigative Site", "city": "Montreal", "state": "Quebec", "zip": "H3T 1E2", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Novartis Investigative Site", "city": "Brno", "state": "Czech Republic", "zip": "656 91", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "Novartis Investigative Site", "city": "Karlovy Vary", "state": "Czech Republic", "zip": "360 66", "country": "Czechia", "geoPoint": {"lat": 50.23271, "lon": 12.87117}}, {"facility": "Novartis Investigative Site", "city": "Liberec", "state": "Czech Republic", "zip": "460 63", "country": "Czechia", "geoPoint": {"lat": 50.76711, "lon": 15.05619}}, {"facility": "Novartis Investigative Site", "city": "Tabor", "state": "Czech Republic", "zip": "39003", "country": "Czechia", "geoPoint": {"lat": 49.41441, "lon": 14.6578}}, {"facility": "Novartis Investigative Site", "city": "Trebic", "state": "Czech Republic", "zip": "674 01", "country": "Czechia", "geoPoint": {"lat": 49.21492, "lon": 15.88166}}, {"facility": "Novartis Investigative Site", "city": "Beroun", "state": "CZE", "zip": "26601", "country": "Czechia", "geoPoint": {"lat": 49.96382, "lon": 14.072}}, {"facility": "Novartis Investigative Site", "city": "Ostrava", "state": "CZE", "zip": "72880", "country": "Czechia", "geoPoint": {"lat": 49.83465, "lon": 18.28204}}, {"facility": "Novartis Investigative Site", "city": "Brno Bohunice", "zip": "625 00", "country": "Czechia"}, {"facility": "Novartis Investigative Site", "city": "JIhlava", "zip": "586 01", "country": "Czechia", "geoPoint": {"lat": 49.3961, "lon": 15.59124}}, {"facility": "Novartis Investigative Site", "city": "Kolin", "zip": "280 20", "country": "Czechia", "geoPoint": {"lat": 50.02806, "lon": 15.1998}}, {"facility": "Novartis Investigative Site", "city": "Olomouc", "zip": "775 20", "country": "Czechia", "geoPoint": {"lat": 49.59552, "lon": 17.25175}}, {"facility": "Novartis Investigative Site", "city": "Praha 10", "zip": "100 34", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Praha", "zip": "12808", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Slany", "zip": "274 01", "country": "Czechia", "geoPoint": {"lat": 50.23046, "lon": 14.08693}}, {"facility": "Novartis Investigative Site", "city": "Amiens", "zip": "80054", "country": "France", "geoPoint": {"lat": 49.9, "lon": 2.3}}, {"facility": "Novartis Investigative Site", "city": "Besancon cedex", "zip": "25030", "country": "France", "geoPoint": {"lat": 47.24878, "lon": 6.01815}}, {"facility": "Novartis Investigative Site", "city": "Paris cedex 10", "zip": "75010", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "Novartis Investigative Site", "city": "Paris", "zip": "75012", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "Novartis Investigative Site", "city": "Toulouse Cedex", "zip": "31059", "country": "France", "geoPoint": {"lat": 43.60426, "lon": 1.44367}}, {"facility": "Novartis Investigative Site", "city": "Tourcoing", "zip": "59200", "country": "France", "geoPoint": {"lat": 50.72391, "lon": 3.16117}}, {"facility": "Novartis Investigative Site", "city": "Valenciennes", "zip": "59300", "country": "France", "geoPoint": {"lat": 50.35, "lon": 3.53333}}, {"facility": "Novartis Investigative Site", "city": "Mannheim", "state": "Baden-Wuerttemberg", "zip": "68305", "country": "Germany", "geoPoint": {"lat": 49.4891, "lon": 8.46694}}, {"facility": "Novartis Investigative Site", "city": "Regensburg", "state": "Bavaria", "zip": "93053", "country": "Germany", "geoPoint": {"lat": 49.01513, "lon": 12.10161}}, {"facility": "Novartis Investigative Site", "city": "Leverkusen", "state": "Nordrhein-Westfalen", "zip": "51375", "country": "Germany", "geoPoint": {"lat": 51.0303, "lon": 6.98432}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13353", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Dortmund", "zip": "44379", "country": "Germany", "geoPoint": {"lat": 51.51494, "lon": 7.466}}, {"facility": "Novartis Investigative Site", "city": "Erfurt", "zip": "99089", "country": "Germany", "geoPoint": {"lat": 50.9787, "lon": 11.03283}}, {"facility": "Novartis Investigative Site", "city": "Essen", "zip": "45356", "country": "Germany", "geoPoint": {"lat": 51.45657, "lon": 7.01228}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "65929", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Gottingen", "zip": "37075", "country": "Germany", "geoPoint": {"lat": 51.53443, "lon": 9.93228}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "20246", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Jena", "zip": "07740", "country": "Germany", "geoPoint": {"lat": 50.92878, "lon": 11.5899}}, {"facility": "Novartis Investigative Site", "city": "Koeln-Nippes", "zip": "50733", "country": "Germany", "geoPoint": {"lat": 50.93333, "lon": 6.95}}, {"facility": "Novartis Investigative Site", "city": "Langen", "zip": "63225", "country": "Germany", "geoPoint": {"lat": 49.98955, "lon": 8.66852}}, {"facility": "Novartis Investigative Site", "city": "L\u00fcbeck", "zip": "23569", "country": "Germany", "geoPoint": {"lat": 53.86893, "lon": 10.68729}}, {"facility": "Novartis Investigative Site", "city": "Magdeburg", "zip": "39120", "country": "Germany", "geoPoint": {"lat": 52.12773, "lon": 11.62916}}, {"facility": "Novartis Investigative Site", "city": "Mainz", "zip": "55131", "country": "Germany", "geoPoint": {"lat": 49.98419, "lon": 8.2791}}, {"facility": "Novartis Investigative Site", "city": "Moenchengladbach", "zip": "41063", "country": "Germany", "geoPoint": {"lat": 51.18539, "lon": 6.44172}}, {"facility": "Novartis Investigative Site", "city": "Neuwied", "zip": "56564", "country": "Germany", "geoPoint": {"lat": 50.4336, "lon": 7.47057}}, {"facility": "Novartis Investigative Site", "city": "Oldenburg", "zip": "26133", "country": "Germany", "geoPoint": {"lat": 53.14118, "lon": 8.21467}}, {"facility": "Novartis Investigative Site", "city": "Ruesselsheim", "zip": "65428", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Witten", "zip": "58455", "country": "Germany", "geoPoint": {"lat": 51.44362, "lon": 7.35258}}, {"facility": "Novartis Investigative Site", "city": "Bergamo", "state": "BG", "zip": "24127", "country": "Italy", "geoPoint": {"lat": 45.69601, "lon": 9.66721}}, {"facility": "Novartis Investigative Site", "city": "Cremona", "state": "CR", "zip": "26100", "country": "Italy", "geoPoint": {"lat": 45.13325, "lon": 10.02129}}, {"facility": "Novartis Investigative Site", "city": "Roma", "state": "RM", "zip": "00152", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "Novartis Investigative Site", "city": "Milano", "zip": "20142", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"facility": "Novartis Investigative Site", "city": "El Chouf", "state": "LBN", "zip": "1503201002", "country": "Lebanon"}, {"facility": "Novartis Investigative Site", "city": "Ashrafieh", "zip": "166830", "country": "Lebanon"}, {"facility": "Novartis Investigative Site", "city": "Beirut", "zip": "1107 2020", "country": "Lebanon", "geoPoint": {"lat": 33.88894, "lon": 35.49442}}, {"facility": "Novartis Investigative Site", "city": "Beirut", "country": "Lebanon", "geoPoint": {"lat": 33.88894, "lon": 35.49442}}, {"facility": "Novartis Investigative Site", "city": "Saida", "zip": "652", "country": "Lebanon"}, {"facility": "Novartis Investigative Site", "city": "Alesund", "zip": "NO-6026", "country": "Norway", "geoPoint": {"lat": 62.47225, "lon": 6.15492}}, {"facility": "Novartis Investigative Site", "city": "Bergen", "zip": "5009", "country": "Norway", "geoPoint": {"lat": 60.39299, "lon": 5.32415}}, {"facility": "Novartis Investigative Site", "city": "Gralum", "zip": "1714", "country": "Norway", "geoPoint": {"lat": 59.29048, "lon": 11.06668}}, {"facility": "Novartis Investigative Site", "city": "Lillehammer", "zip": "2629", "country": "Norway", "geoPoint": {"lat": 61.11514, "lon": 10.46628}}, {"facility": "Novartis Investigative Site", "city": "Lodz", "state": "Lodzkie", "zip": "90 549", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Novartis Investigative Site", "city": "Bialystok", "zip": "15-276", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Novartis Investigative Site", "city": "Krakow", "zip": "31202", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "61-848", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Pulawy", "zip": "24100", "country": "Poland", "geoPoint": {"lat": 51.41655, "lon": 21.96939}}, {"facility": "Novartis Investigative Site", "city": "Warszawa", "zip": "04-749", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Novartis Investigative Site", "city": "Wroclaw", "zip": "50 420", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "Novartis Investigative Site", "city": "Vila Real", "state": "Portuigal", "zip": "5000-508", "country": "Portugal", "geoPoint": {"lat": 41.30062, "lon": -7.74413}}, {"facility": "Novartis Investigative Site", "city": "Amadora", "zip": "2720-276", "country": "Portugal", "geoPoint": {"lat": 38.75382, "lon": -9.23083}}, {"facility": "Novartis Investigative Site", "city": "Aveiro", "zip": "3814-501", "country": "Portugal", "geoPoint": {"lat": 40.64427, "lon": -8.64554}}, {"facility": "Novartis Investigative Site", "city": "Coimbra", "zip": "3000-075", "country": "Portugal", "geoPoint": {"lat": 40.20564, "lon": -8.41955}}, {"facility": "Novartis Investigative Site", "city": "Covilha", "zip": "6200-251", "country": "Portugal", "geoPoint": {"lat": 40.28601, "lon": -7.50396}}, {"facility": "Novartis Investigative Site", "city": "Guimaraes", "zip": "4835-044", "country": "Portugal", "geoPoint": {"lat": 41.44443, "lon": -8.29619}}, {"facility": "Novartis Investigative Site", "city": "Leiria", "zip": "2410-187", "country": "Portugal", "geoPoint": {"lat": 39.74362, "lon": -8.80705}}, {"facility": "Novartis Investigative Site", "city": "Lisboa", "zip": "1495 005", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"facility": "Novartis Investigative Site", "city": "Lisboa", "zip": "1500 650", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"facility": "Novartis Investigative Site", "city": "Lisboa", "zip": "1649-035", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"facility": "Novartis Investigative Site", "city": "Porto", "zip": "4099-001", "country": "Portugal", "geoPoint": {"lat": 41.14961, "lon": -8.61099}}, {"facility": "Novartis Investigative Site", "city": "Porto", "zip": "4200-319", "country": "Portugal", "geoPoint": {"lat": 41.14961, "lon": -8.61099}}, {"facility": "Novartis Investigative Site", "city": "Gatchina", "zip": "188300", "country": "Russian Federation", "geoPoint": {"lat": 59.57639, "lon": 30.12833}}, {"facility": "Novartis Investigative Site", "city": "Kazan", "zip": "420012", "country": "Russian Federation", "geoPoint": {"lat": 55.78874, "lon": 49.12214}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "117292", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "117556", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "123182", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "193312", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "199106", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150047", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Dammam", "zip": "31463", "country": "Saudi Arabia", "geoPoint": {"lat": 26.43442, "lon": 50.10326}}, {"facility": "Novartis Investigative Site", "city": "Jeddah", "zip": "21499", "country": "Saudi Arabia", "geoPoint": {"lat": 21.54238, "lon": 39.19797}}, {"facility": "Novartis Investigative Site", "city": "Riyadh", "zip": "11211", "country": "Saudi Arabia", "geoPoint": {"lat": 24.68773, "lon": 46.72185}}, {"facility": "Novartis Investigative Site", "city": "Dunajska Streda", "state": "Slovak Republic", "zip": "92901", "country": "Slovakia", "geoPoint": {"lat": 47.99268, "lon": 17.61211}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "state": "Slovak Republic", "zip": "4190", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Liptovsky Mikulas", "state": "Slovak Republic", "zip": "031 23", "country": "Slovakia", "geoPoint": {"lat": 49.08061, "lon": 19.62218}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "zip": "826 06", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "zip": "833 48", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Dolny Kubin", "zip": "026 01", "country": "Slovakia", "geoPoint": {"lat": 49.20983, "lon": 19.30341}}, {"facility": "Novartis Investigative Site", "city": "Martin", "zip": "036 59", "country": "Slovakia", "geoPoint": {"lat": 49.06651, "lon": 18.92399}}, {"facility": "Novartis Investigative Site", "city": "Presov", "zip": "080 01", "country": "Slovakia", "geoPoint": {"lat": 48.99839, "lon": 21.23393}}, {"facility": "Novartis Investigative Site", "city": "Rimavska Sobota", "zip": "97912", "country": "Slovakia", "geoPoint": {"lat": 48.38284, "lon": 20.02239}}, {"facility": "Novartis Investigative Site", "city": "Trnava", "zip": "917 75", "country": "Slovakia", "geoPoint": {"lat": 48.37741, "lon": 17.58723}}, {"facility": "Novartis Investigative Site", "city": "Malaga", "state": "Andalucia", "zip": "29010", "country": "Spain", "geoPoint": {"lat": 36.72016, "lon": -4.42034}}, {"facility": "Novartis Investigative Site", "city": "Sanlucar de Barrameda", "state": "Andalucia", "zip": "11540", "country": "Spain", "geoPoint": {"lat": 36.77808, "lon": -6.3515}}, {"facility": "Novartis Investigative Site", "city": "Sevilla", "state": "Andalucia", "zip": "41009", "country": "Spain", "geoPoint": {"lat": 37.38283, "lon": -5.97317}}, {"facility": "Novartis Investigative Site", "city": "Sevilla", "state": "Andalucia", "zip": "41014", "country": "Spain", "geoPoint": {"lat": 37.38283, "lon": -5.97317}}, {"facility": "Novartis Investigative Site", "city": "Barcelona", "state": "Barcelona/ Cataluny/Espanya", "zip": "08035", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Novartis Investigative Site", "city": "Villamartin", "state": "Cadiz", "zip": "11650", "country": "Spain", "geoPoint": {"lat": 36.85979, "lon": -5.64485}}, {"facility": "Novartis Investigative Site", "city": "Valencia", "state": "Comunidad Valenciana", "zip": "46010", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"facility": "Novartis Investigative Site", "city": "Valencia", "state": "Comunidad Valenciana", "zip": "46014", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"facility": "Novartis Investigative Site", "city": "Valencia", "state": "Comunidad Valenciana", "zip": "46026", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"facility": "Novartis Investigative Site", "city": "A Coruna", "state": "Galicia", "zip": "15006", "country": "Spain", "geoPoint": {"lat": 43.37135, "lon": -8.396}}, {"facility": "Novartis Investigative Site", "city": "La Coruna", "state": "Galicia", "zip": "15006", "country": "Spain", "geoPoint": {"lat": 43.37135, "lon": -8.396}}, {"facility": "Novartis Investigative Site", "city": "Olot", "state": "Girona", "zip": "17800", "country": "Spain", "geoPoint": {"lat": 42.18096, "lon": 2.49012}}, {"facility": "Novartis Investigative Site", "city": "Mostoles", "state": "Madrid", "zip": "28935", "country": "Spain", "geoPoint": {"lat": 40.32234, "lon": -3.86496}}, {"facility": "Novartis Investigative Site", "city": "El Palmar", "state": "Murcia", "zip": "30120", "country": "Spain", "geoPoint": {"lat": 37.93939, "lon": -1.16095}}, {"facility": "Novartis Investigative Site", "city": "Las Palmas de Gran Canaria", "zip": "35010", "country": "Spain", "geoPoint": {"lat": 28.09973, "lon": -15.41343}}, {"facility": "Novartis Investigative Site", "city": "Madrid", "zip": "28222", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Novartis Investigative Site", "city": "Goteborg", "zip": "413 45", "country": "Sweden", "geoPoint": {"lat": 57.70716, "lon": 11.96679}}, {"facility": "Novartis Investigative Site", "city": "Joenkoeping", "zip": "551 85", "country": "Sweden"}, {"facility": "Novartis Investigative Site", "city": "Basel", "zip": "4031", "country": "Switzerland", "geoPoint": {"lat": 47.55839, "lon": 7.57327}}, {"facility": "Novartis Investigative Site", "city": "Geneve 14", "zip": "1211", "country": "Switzerland", "geoPoint": {"lat": 46.20222, "lon": 6.14569}}, {"facility": "Novartis Investigative Site", "city": "Eskisehir", "state": "Meselik", "zip": "26480", "country": "Turkey", "geoPoint": {"lat": 39.77667, "lon": 30.52056}}, {"facility": "Novartis Investigative Site", "city": "Ankara", "zip": "06100", "country": "Turkey", "geoPoint": {"lat": 39.91987, "lon": 32.85427}}, {"facility": "Novartis Investigative Site", "city": "Istanbul", "zip": "34304", "country": "Turkey", "geoPoint": {"lat": 41.01384, "lon": 28.94966}}, {"facility": "Novartis Investigative Site", "city": "Kocaeli", "zip": "41380", "country": "Turkey", "geoPoint": {"lat": 39.62497, "lon": 27.51145}}, {"facility": "Novartis Investigative Site", "city": "Mersin", "zip": "33343", "country": "Turkey", "geoPoint": {"lat": 36.79526, "lon": 34.61792}}, {"facility": "Novartis Investigative Site", "city": "Sivas", "zip": "58140", "country": "Turkey", "geoPoint": {"lat": 39.74833, "lon": 37.01611}}, {"facility": "Novartis Investigative Site", "city": "Westcliff on Sea", "state": "Essex", "zip": "SS0 0RY", "country": "United Kingdom", "geoPoint": {"lat": 51.54424, "lon": 0.69179}}, {"facility": "Novartis Investigative Site", "city": "Basingstoke", "state": "Hampshire", "zip": "RG24 9NA", "country": "United Kingdom", "geoPoint": {"lat": 51.26249, "lon": -1.08708}}, {"facility": "Novartis Investigative Site", "city": "Ashford", "state": "Kent", "zip": "TN24 0LZ", "country": "United Kingdom", "geoPoint": {"lat": 51.14648, "lon": 0.87376}}, {"facility": "Novartis Investigative Site", "city": "Bridgend", "state": "Mid Glamorgan", "zip": "CF31 1RQ", "country": "United Kingdom", "geoPoint": {"lat": 51.50583, "lon": -3.57722}}, {"facility": "Novartis Investigative Site", "city": "Portadown", "state": "Nothern Ireland", "zip": "BT63 5QQ", "country": "United Kingdom", "geoPoint": {"lat": 54.42302, "lon": -6.44434}}, {"facility": "Novartis Investigative Site", "city": "Sunderland", "state": "Tyne And Wear", "zip": "SR4 7TP", "country": "United Kingdom", "geoPoint": {"lat": 54.90465, "lon": -1.38222}}, {"facility": "Novartis Investigative Site", "city": "Blackpool", "zip": "FY3 8NR", "country": "United Kingdom", "geoPoint": {"lat": 53.81667, "lon": -3.05}}, {"facility": "Novartis Investigative Site", "city": "Leeds", "zip": "LS1 3EX", "country": "United Kingdom", "geoPoint": {"lat": 53.79648, "lon": -1.54785}}, {"facility": "Novartis Investigative Site", "city": "Leicester", "zip": "LE 3 9QP", "country": "United Kingdom", "geoPoint": {"lat": 52.6386, "lon": -1.13169}}, {"facility": "Novartis Investigative Site", "city": "Liverpool", "zip": "L9 7AL", "country": "United Kingdom", "geoPoint": {"lat": 53.41058, "lon": -2.97794}}, {"facility": "Novartis Investigative Site", "city": "London", "zip": "EC14 7BE", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "Novartis Investigative Site", "city": "Middlesbrough", "zip": "TS4 3BW", "country": "United Kingdom", "geoPoint": {"lat": 54.57623, "lon": -1.23483}}, {"facility": "Novartis Investigative Site", "city": "Newcastle Upon Tyne", "zip": "NE1 4LP", "country": "United Kingdom", "geoPoint": {"lat": 54.97328, "lon": -1.61396}}, {"facility": "Novartis Investigative Site", "city": "Norwich", "zip": "NR4 7UY", "country": "United Kingdom", "geoPoint": {"lat": 52.62783, "lon": 1.29834}}, {"facility": "Novartis Investigative Site", "city": "Swindon", "zip": "SN3 6BB", "country": "United Kingdom", "geoPoint": {"lat": 51.55797, "lon": -1.78116}}, {"facility": "Novartis Investigative Site", "city": "York", "zip": "YO31 8HE", "country": "United Kingdom", "geoPoint": {"lat": 53.95763, "lon": -1.08271}}]}, "referencesModule": {"references": [{"pmid": "32800508", "type": "DERIVED", "citation": "Pascual-Figal D, Wachter R, Senni M, Bao W, Noe A, Schwende H, Butylin D, Prescott MF; TRANSITION Investigators. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. JACC Heart Fail. 2020 Oct;8(10):822-833. doi: 10.1016/j.jchf.2020.05.012. Epub 2020 Aug 12."}, {"pmid": "31820537", "type": "DERIVED", "citation": "Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D; TRANSITION Investigators. Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study. Eur J Heart Fail. 2020 Feb;22(2):303-312. doi: 10.1002/ejhf.1670. Epub 2019 Dec 9."}, {"pmid": "31134724", "type": "DERIVED", "citation": "Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bohmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, Noe A, Schwende H, Bao W, Butylin D, Pascual-Figal D; TRANSITION Investigators. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail. 2019 Aug;21(8):998-1007. doi: 10.1002/ejhf.1498. Epub 2019 May 27."}, {"pmid": "29239515", "type": "DERIVED", "citation": "Pascual-Figal D, Wachter R, Senni M, Belohlavek J, Noe A, Carr D, Butylin D. Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. ESC Heart Fail. 2018 Apr;5(2):327-336. doi: 10.1002/ehf2.12246. Epub 2017 Dec 14."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "The study consisted of 3 Epochs: the Screening Epoch (from signing of informed consent form to randomization), the treatment epoch (10 weeks following randomization), and a 16 weeks Follow-up Epoch following treatment epoch.", "recruitmentDetails": "Patients were randomized to pre-discharge group or post-discharged group.", "groups": [{"id": "FG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "FG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "comment": "Randomized", "achievements": [{"groupId": "FG000", "numSubjects": "500"}, {"groupId": "FG001", "numSubjects": "502"}]}, {"type": "Started 10 Weeks Treatment Epoch", "achievements": [{"groupId": "FG000", "numSubjects": "497"}, {"groupId": "FG001", "numSubjects": "501"}]}, {"type": "Completed 10 Weeks Treatment Epoch", "achievements": [{"groupId": "FG000", "numSubjects": "460"}, {"groupId": "FG001", "numSubjects": "455"}]}, {"type": "COMPLETED", "comment": "Completed 16 weeks follow-up epoch", "achievements": [{"groupId": "FG000", "numSubjects": "425"}, {"groupId": "FG001", "numSubjects": "419"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "75"}, {"groupId": "FG001", "numSubjects": "83"}]}], "dropWithdraws": [{"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Protocol Deviation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Non-compliance with study treatment", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "21"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "10"}, {"groupId": "FG001", "numSubjects": "8"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "19"}]}, {"type": "Did not enter follow-up epoch", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "10"}]}, {"type": "Death - no study drug received", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}]}, {"type": "Mis-randomized (not in treatment epoch)", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "BG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "500"}, {"groupId": "BG001", "value": "502"}, {"groupId": "BG002", "value": "1002"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "66.7", "spread": "12.27"}, {"groupId": "BG001", "value": "67.0", "spread": "11.67"}, {"groupId": "BG002", "value": "66.8", "spread": "11.97"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "126"}, {"groupId": "BG001", "value": "125"}, {"groupId": "BG002", "value": "251"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "374"}, {"groupId": "BG001", "value": "377"}, {"groupId": "BG002", "value": "751"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Caucasian", "measurements": [{"groupId": "BG000", "value": "488"}, {"groupId": "BG001", "value": "486"}, {"groupId": "BG002", "value": "974"}]}, {"title": "Black", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "13"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "10"}]}, {"title": "Native American", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Unknown", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "2"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Percentage of Patients Achieving the Target Dose of LCZ696 200 mg Bid at 10 Weeks Post Randomization", "description": "Percentage of patients achieving and maintaining LCZ696 200 mg bid for at least 2 weeks leading to Week 10", "populationDescription": "Safety Population (SAF). The SAF consisted of all randomized subjects who received at least one dose of study drug with the exception of those patients who were inadvertently randomized into the study. Subjects were analyzed according to treatment actually received.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "10 weeks after Randomization", "groups": [{"id": "OG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "OG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "493"}, {"groupId": "OG001", "value": "489"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "224"}, {"groupId": "OG001", "value": "248"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.099", "statisticalMethod": "Cochran-Mantel-Haenszel", "paramType": "Risk Ratio (RR)", "paramValue": "0.896", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.786", "ciUpperLimit": "1.021"}]}, {"type": "SECONDARY", "title": "Percentage of Patients Achieving and Maintaining Either LCZ696 100 mg and/or 200 mg Bid", "description": "Percentage of patients achieving and maintaining either LCZ696 100 mg and/or 200 mg bid for at least 2 weeks leading to Week 10", "populationDescription": "Safety Population (SAF). The SAF consisted of all randomized subjects who received at least one dose of study drug with the exception of those patients who were inadvertently randomized into the study. Subjects were analyzed according to treatment actually received.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "10 weeks after Randomization", "groups": [{"id": "OG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "OG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "493"}, {"groupId": "OG001", "value": "489"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "306"}, {"groupId": "OG001", "value": "335"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.034", "statisticalMethod": "Cochran-Mantel-Haenszel", "paramType": "Risk Ratio (RR)", "paramValue": "0.906", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.827", "ciUpperLimit": "0.993"}]}, {"type": "SECONDARY", "title": "Percentage of Patients Achieving and Maintaining Any Dose of LCZ696", "description": "Percentage of patients achieving any dose of LCZ696 for at least 2 weeks leading to 10 weeks of treatment", "populationDescription": "Safety Population (SAF). The SAF consisted of all randomized subjects who received at least one dose of study drug with the exception of those patients who were inadvertently randomized into the study. Subjects were analyzed according to treatment actually received.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "10 weeks after Randomization", "groups": [{"id": "OG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "OG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "493"}, {"groupId": "OG001", "value": "489"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "424"}, {"groupId": "OG001", "value": "438"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.089", "statisticalMethod": "Cochran-Mantel-Haenszel", "paramType": "Risk Ratio (RR)", "paramValue": "0.960", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.916", "ciUpperLimit": "1.006"}]}, {"type": "SECONDARY", "title": "Percentage of Patients Permanently Discontinued From Treatment", "description": "Percentage of patients permanently discontinued from LCZ696 (1) up to week 10 due to AEs, and (2) up to week 26 due to any reasons", "populationDescription": "Safety Population (SAF). The SAF consisted of all randomized subjects who received at least one dose of study drug with the exception of those patients who were inadvertently randomized into the study. Subjects were analyzed according to treatment actually received.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "10 weeks after Randomization AND 26 weeks after randomization", "groups": [{"id": "OG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "OG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "493"}, {"groupId": "OG001", "value": "489"}]}], "classes": [{"title": "up to week 10 due to AEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "24"}]}]}, {"title": "up to week 26 due to any reasons", "categories": [{"measurements": [{"groupId": "OG000", "value": "83"}, {"groupId": "OG001", "value": "78"}]}]}]}, {"type": "POST_HOC", "title": "All Collected Deaths", "description": "Pre-treatment deaths were collected from randomization until first treatment with LCZ696. The period from randomization to first treatment was up to 14 days.\n\nOn-treatment deaths were collected from first treatment with LCZ696 until 26 weeks post randomization.", "populationDescription": "Safety Population (SAF) and randomized patients who died prior to first dose of study drug. The SAF consisted of all randomized subjects who received at least one dose of study drug with the exception of those patients who were inadvertently randomized into the study. Subjects were analyzed according to treatment actually received.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "From randomization until 26 weeks after randomization", "groups": [{"id": "OG000", "title": "LCZ696 Pre-discharge Treatment Initiation", "description": "Patients received first dose at any point after Randomization but no later than 12 h before discharge."}, {"id": "OG001", "title": "LCZ696 Post-discharge Treatment Initiation", "description": "Patients received first dose after discharge and up to 14 days thereafter."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "494"}, {"groupId": "OG001", "value": "491"}]}], "classes": [{"title": "Pre-treatment deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "On-treatment deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "13"}]}]}, {"title": "All deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "24"}, {"groupId": "OG001", "value": "15"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "From start of treatment until 26 weeks after randomization", "description": "Analysis is based on the Safety Population (SAF). It consists of all randomized patients who received at least one dose of study drug.\n\nDeaths not included in the SAF (i.e. did not receive study drug) are presented separately in the Participant Flow and .\n\nPatients are analyzed according to treatment actually received.", "eventGroups": [{"id": "EG000", "title": "Pre-discharge", "description": "Pre-discharge", "deathsNumAffected": 23, "deathsNumAtRisk": 493, "seriousNumAffected": 159, "seriousNumAtRisk": 493, "otherNumAffected": 200, "otherNumAtRisk": 493}, {"id": "EG001", "title": "Post-discharge", "description": "Post-discharge", "deathsNumAffected": 13, "deathsNumAtRisk": 489, "seriousNumAffected": 134, "seriousNumAtRisk": 489, "otherNumAffected": 201, "otherNumAtRisk": 489}, {"id": "EG002", "title": "All Patients", "description": "All patients", "deathsNumAffected": 36, "deathsNumAtRisk": 982, "seriousNumAffected": 293, "seriousNumAtRisk": 982, "otherNumAffected": 401, "otherNumAtRisk": 982}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Hypocoagulable state", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Leukocytosis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Splenic haemorrhage", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Acute coronary syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Arteriosclerosis coronary artery", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 982}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Atrial tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Atrioventricular block complete", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 46, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 45, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 91, "numAtRisk": 982}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 20, "numAtRisk": 982}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Cardio-respiratory arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Cardiogenic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 982}]}, {"term": "Cardiomyopathy", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Congestive cardiomyopathy", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Ischaemic cardiomyopathy", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Left ventricular failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Low cardiac output syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Mitral valve incompetence", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Myocardial fibrosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Myocardial ischaemia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Palpitations", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Sinus arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Sinus node dysfunction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Ventricular arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Ventricular extrasystoles", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Ventricular fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Tracheo-oesophageal fistula", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hypothyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Diarrhoea haemorrhagic", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Gastrointestinal inflammation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Intestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Lip swelling", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Melaena", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Rectal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Subileus", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Asthenia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Impaired healing", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Multiple organ dysfunction syndrome", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 982}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Sudden cardiac death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Sudden death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Acute hepatic failure", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Hepatic function abnormal", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hepatitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hyperbilirubinaemia", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Jaundice cholestatic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Bacterial sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Biliary sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Catheter site abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Device related infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Diarrhoea infectious", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Endocarditis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Epididymitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Erysipelas", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Gangrene", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Localised infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Lower respiratory tract infection viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Lung infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 15, "numAtRisk": 982}]}, {"term": "Postoperative wound infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Q fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Septic phlebitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Septic shock", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 982}]}, {"term": "Urosepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Concussion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Craniocerebral injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Femoral neck fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Hip fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Humerus fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Multiple injuries", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Patella fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Post procedural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Spinal fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Subdural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Transplant failure", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Blood creatinine increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Cardiac output decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Ejection fraction abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Ejection fraction decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "General physical condition abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Heart rate abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hepatic enzyme abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hepatic enzyme increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "International normalised ratio increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Weight increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Fluid overload", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Gout", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hyperglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 982}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hyponatraemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Bursitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Fistula", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Musculoskeletal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Myalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Adenocarcinoma gastric", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Brain neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Lung neoplasm malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Malignant neoplasm of ampulla of Vater", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Malignant peritoneal neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Metastases to liver", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Metastases to lung", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Rectal adenocarcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Transitional cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Aphasia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Autonomic nervous system imbalance", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Brain injury", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Cerebral arteriosclerosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Cerebral ischaemia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Cognitive disorder", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Extrapyramidal disorder", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Hypoxic-ischaemic encephalopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Ischaemic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Loss of consciousness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Presyncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Sciatica", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 982}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Device battery issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Device dislocation", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Insomnia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 19, "numAtRisk": 982}]}, {"term": "Chronic kidney disease", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 982}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 982}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 982}]}, {"term": "Benign prostatic hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Acute pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Acute respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 982}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 982}]}, {"term": "Haemoptysis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Mediastinal haematoma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Orthopnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Pulmonary congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 982}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Diabetic foot", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 982}]}, {"term": "Skin ulcer", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Aortic aneurysm", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 8, "numAtRisk": 982}]}, {"term": "Peripheral arterial occlusive disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 982}]}, {"term": "Peripheral vascular disorder", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 982}]}], "otherEvents": [{"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 17, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 29, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 46, "numAtRisk": 982}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 20, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 26, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 46, "numAtRisk": 982}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 29, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 19, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 48, "numAtRisk": 982}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 67, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 59, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 126, "numAtRisk": 982}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 32, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 30, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 62, "numAtRisk": 982}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 36, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 24, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 60, "numAtRisk": 982}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 71, "numAtRisk": 493}, {"groupId": "EG001", "numAffected": 67, "numAtRisk": 489}, {"groupId": "EG002", "numAffected": 138, "numAtRisk": 982}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "email": "novartis.email@novartis.com", "phone": "862-778-8300"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2016-07-18", "uploadDate": "2019-06-20T04:47", "filename": "Prot_000.pdf", "size": 1160893}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2018-10-18", "uploadDate": "2019-06-20T04:48", "filename": "SAP_001.pdf", "size": 451081}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000549068", "term": "Sacubitril and valsartan sodium hydrate drug combination"}], "ancestors": [{"id": "D000057911", "term": "Angiotensin Receptor Antagonists"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M350410", "name": "Sacubitril and valsartan sodium hydrate drug combination", "asFound": "Allopurinol", "relevance": "HIGH"}, {"id": "M301", "name": "Valsartan", "relevance": "LOW"}, {"id": "M28916", "name": "Angiotensin Receptor Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AnAg", "name": "Antihypertensive Agents"}]}}, "hasResults": true}